During the past decade, MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Amgen" with 3 trials sponsored, "AO GENERIUM" with 1 trials sponsored, "Biocad" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy" #1 collaborator was "Exelixis" with 2 trials as a collaborator and "Chugai" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Carcinoma, Renal Cell" (2 trials), "Cervical Cancer" (2 trials) and "Chemotherapy-induced Thrombocytopenia" (2 trials). Many other conditions were trialed in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy" in a lesser frequency.

Most popular intervention types in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy" are "Drug" (13 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Docetaxel" (3 trials), "Cabozantinib" (2 trials) and "Romiplostim" (2 trials). Other intervention names were less common.

The vast majority of trials in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

MEDSI Clinical Hospital on Pyatnitsky Highway; Department of antitumor drug therapy has several departments that took part in Clinical trials: "Clinical and Diagnostic Center with an outpatient department under the Presidential Executive Office" - 3 trials